NRC
SNY icon

New Republic Capital’s Sanofi SNY Stock Holding History

New Republic Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,462
Closed -$313K – 371
2025
Q4 		$313K Buy
+6,462
New +$320K 0.08% 213

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

New Republic Capital's SNY Position: Q1 2026 in Review

New Republic Capital sold out of Sanofi (SNY) in Q1 2026, closing a stake of 6,462 shares — an estimated $313K sold.

New Republic Capital first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $313K in Q4 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • New Republic Capital reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • New Republic Capital sold 6,462 Sanofi shares in Q1 2026, an estimated $313K.
  • New Republic Capital first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
  • New Republic Capital's Sanofi position peaked at $313K in Q4 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.